US BANCORP \DE\ - IMMUCELL CORP ownership

IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 32 filers reported holding IMMUCELL CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of IMMUCELL CORP
ValueSharesWeighting
Q3 2023$3,204
+6.8%
6000.0%0.00%
Q2 2023$3,000
-2.2%
6000.0%0.00%
Q1 2023$3,066
-16.2%
6000.0%0.00%
Q4 2022$3,660
-8.5%
6000.0%0.00%
Q3 2022$4,000
-20.0%
6000.0%0.00%
Q2 2022$5,000
-16.7%
6000.0%0.00%
Q1 2022$6,000
+20.0%
6000.0%0.00%
Q4 2021$5,000
-16.7%
6000.0%0.00%
Q3 2021$6,0000.0%6000.0%0.00%
Q2 2021$6,0000.0%6000.0%0.00%
Q1 2021$6,000600
+2400.0%
0.00%
Q4 2013$0240.0%0.00%
Q3 2013$0240.0%0.00%
Q2 2013$0240.00%
Other shareholders
IMMUCELL CORP shareholders Q2 2023
NameSharesValueWeighting ↓
PERRITT CAPITAL MANAGEMENT INC 154,300$1,285,0000.38%
HEARTLAND ADVISORS INC 199,600$1,663,0000.11%
Minerva Advisors LLC 14,559$121,0000.06%
Essex Financial Services, Inc. 23,776$198,0000.04%
SHUFRO ROSE & CO LLC 50,791$423,0000.04%
INGALLS & SNYDER LLC 91,511$762,0000.03%
RBF Capital, LLC 13,086$109,0000.01%
FLAGSHIP HARBOR ADVISORS, LLC 3,000$26,0000.01%
Renaissance Technologies 96,100$801,0000.00%
MORGAN STANLEY 11,732$98,0000.00%
View complete list of IMMUCELL CORP shareholders